Drug intelligence / Profile preview

compound foercao mixture

Development stage: Preclinical
Administration: Oral

Overview

Compound FoErCao Mixture is a traditional Chinese medicine formulation used primarily for its anti-inflammatory effects, particularly in the management of airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The mixture contains multiple herbal components, predominantly from the genus Gnaphalium, which are rich in flavonoids, phenolic acids, alkaloids, and terpenoids. These phytochemicals are believed to contribute to its pharmacological activities. The exact mechanism of action is not fully elucidated but is thought to involve modulation of inflammatory pathways and antioxidant effects[6][8]. Compound FoErCao Mixture is typically prepared as a compounded medication tailored for individual patient needs.

Other names: compound foercao mixture

Beyond the preview

Go deeper on compound foercao mixture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound foercao mixture.

Explore the full profile